Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
148,308,742
-
Shares change
-
+14,773,090
-
Total reported value, excl. options
-
$1,096,923,417
-
Value change
-
+$112,419,698
-
Put/Call ratio
-
24.18%
-
Number of buys
-
74
-
Number of sells
-
-49
-
Price
-
$7.4
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q3 2016
167 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q3 2016.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 148,308,742 shares
of 308,713,740 outstanding shares and own 48.04% of the company stock.
Largest 10 shareholders include FMR LLC (21,320,863 shares), PERCEPTIVE ADVISORS LLC (14,116,644 shares), Redmile Group, LLC (12,751,536 shares), VANGUARD GROUP INC (7,956,543 shares), JENNISON ASSOCIATES LLC (7,906,476 shares), JANUS CAPITAL MANAGEMENT LLC (7,708,080 shares), BlackRock Fund Advisors (6,634,693 shares), Palo Alto Investors, LLC (5,685,388 shares), STATE STREET CORP (5,093,598 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (4,339,335 shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.